PPA selected to participate in upcoming S-CitAD Trial

We are excited to announce the Program for Positive Aging has been selected for the upcoming S-Citalopram for Agitation in Dementia (S-CitAD) trial. The S-CitaD trial is funded by the National Institute on Aging at the National Institutes for Health (NIA/NIH). It will evaluate escitalopram plus structured psychosocial intervention against a placebo plus structured psychosocial intervention for the treatment of agitation in patients with dementia. The S-CitAD Trial will be initiated in summer 2017.